News > Latest NewsWalk News | Sponsor & Foundation News | News in the Parkinson's Disease Community
Medtronicís Brain Device Improves Early-Stage Parkinsonís
Quality of life for patients with early Parkinson’s improved significantly for those getting both treatments of drugs plus deep-brain stimulation
(February 21, 2013) A study published in New England Journal of Medicine showed that quality of life for patients with early Parkinson’s disease improved significantly for those getting both treatments of drugs plus deep-brain stimulation, while it worsened slightly for those given only drugs. This study tracked 251 patients with Parkinson’s for an average of 7.5 years after they were treated with drug therapy, or drugs plus deep-brain stimulation with Medtronic Inc.’s Kinetra or Soletra devices.
To read the complete Bloomberg article, click here.